Table 7.
No MS (N = 111) | MS (N = 29) | P | |
---|---|---|---|
Gender, male/female; n ( % ) | 90/21 (81/19) | 26/3 (90/10) | 0.4 |
Age, years | 48 ± 14 | 49 ± 10 | 0.8 |
BMI, kg/m2 | 25.0 ± 3.8 | 30.7 ± 6.0 | < 0.0001 |
Systolic BP, mmHg | 137 ± 20 | 146 ± 17 | 0.03 |
Diastolic BP, mmHg | 86 ± 11 | 95 ± 15 | 0.003 |
Serum | |||
Glucose, mmol/L | 5.1 ± 0.8 | 5.7 ± 1.1 | 0.01 |
Triglycerides, mmol/L | 1.11 ± 0.45 | 2.24 ± 0.80 | < 0.0001 |
HDL cholesterol, mmol/L | 1.39 ± 0.32 | 0.99 ± 0.18 | < 0.0001 |
Urine | |||
Total volume, L/day | 2.08 ± 0.77 | 2.19 ± 1.23 | 0.7 |
Calcium, mmol/day | 6.9 ± 3.7 | 7.0 ± 3.2 | 0.8 |
Oxalate, mmol/dayb | 298 ± 138 | 327 ± 116 | 0.6 |
Uric acid, mmol/day | 3.27 ± 1.21 | 3.68 ± 1.12 | 0.09 |
pH | 6.07 ± 0.81 | 6.14 ± 0.68 | 0.6 |
Citrate, mEq/day | 9.4 ± 8.3 | 9.4 ± 5.9 | 0.9 |
Sulfate, mmol/day | 24.5 ± 17.7 | 25.4 ± 11.5 | 0.7 |
NAE, mEq/day (calculated) | 66.8 ± 40.8 | 69.5 ± 43.7 | 0.9 |
Creatinine clearance, mL/s | 1.97 ± 0.58 | 2.27 ± 0.67 | 0.02 |
Supersaturation indices | |||
SI CaOx (volume adjusted) | 3.37 ± 1.98 | 4.04 ± 2.78 | 0.5 |
SI Br (volume adjusted) | 1.35 ± 0.92 | 1.59 ± 0.73 | 0.6 |
aValues are expressed as mean ± SD.
bOxalate only available in 25 subjects with no MS and six subjects with the MS.